Latest from RCCA

We have been asked on numerous occasions why would almost 100 oncologists "give up their independence and identity in their community" and become part of Regional Cancer Care Associates (RCCA), a new entity with a single tax identification number?
Andre Goy, MD, MS, chairman, director, and chief of the Lymphoma Division at the John Theurer Cancer Center, discusses the challenges of treating patients with Hodgkin's lymphoma.
"Are you making progress?" is one of the questions you are most frequently being asked as an oncologist-even in social settings.
Regional Cancer Care Associates will collaborate with OncLive to develop informative resources for oncology professionals that advance patient care.
Like you, I get up every day and look at the stack of journals I know I need to read but cannot imagine when I will find the time.
Andre Goy, MD, MS, from the John Theurer Cancer Center, discusses the apparent effectiveness of CD19-targeted CAR-modified T cells as a treatment for patients with various types of lymphoma.
As we approach the end of the year, it is a reasonable time to reflect on what has been accomplished in cancer research and therapeutic development.
A majority of Americans-patients, physicians, hospital executives, business leaders, and elected officials- are bearing witness to the beginning of a change in healthcare reimbursement and delivery that rivals the introduction of the Medicare system in 1965.
Publication Bottom Border
Border Publication